gemcitabine / Generic mfg.  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
2016-005029-36: Vergleich der Lebensqualität bei Patientinnen mit platinsensitivem wiederkehrenden Eierstock-, Eileiter- und Bachfellkrebs bei der Behandlung mit Trabectedin / PLD oder einer platinbasierten Standardtherapie - eine Kooperation der NOGGO und BNGO

Ongoing
4
206
Europe
Trabectedin, Pegylated liposomal Doxorubicin, Carboplatin, Gemzitabin, Placlitaxel, L01XA02, Powder for concentrate for solution for infusion, Concentrate for solution for infusion, Powder for solution for infusion, Yondelis 1 mg powder for solution for infusion, Caelyx, Carboplatin, Gemcitabin, Paclitaxel
NOGGO e.V., PharmaMar, S.A.
Ovarian Cancer, cancer of the ovaries, Diseases [C] - Cancer [C04]
 
 
VIGOR, NCT05583188: Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Active, not recruiting
4
15
US
Aliya Pulsed Electric Fields (PEF) ablation, Nivolumab plus Platinum Doublet Chemotherapy, Carboplatinum, Cipsplatin, Pemetrexed, Gemcitabine, Paclitaxel, Standard of care neoadjuvant therapy, Vinorelbine, Surgical Resection
Galvanize Therapeutics, Inc.
NSCLC
06/24
06/24
ChiCTR2000037670: A Multicenter Study of Neoadjuvant Tislelizumab (BGB-A317, anti-PD-1 antibody) combined with Cisplatin and Gemcitabine for cT2-T4aN0M0 Bladder Urothelial Cancer

Not yet recruiting
4
65
China
Tislelizumab+Gemcitabine+Cisplatin+Radical Cystectomy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ; Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, BeiGene (Beijing) Co., Ltd.
Bladder Urothelial Cancer
 
 
TRANSPARENT, NCT06457503: A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Not yet recruiting
4
100
NA
Toripalimab, JS001, TAB-001, CHS-007, Cisplatin, Gemcitabine, Carboplatin
Coherus Biosciences, Inc.
Nasopharyngeal Cancer Recurrent
12/27
12/27

Download Options